688016 心脉医疗
已收盘 07-22 15:00:00
资讯
新帖
简况
港股异动 | 微创系全线走低 心脉医疗高价收购OMD引监管质疑 野村曾指长期债务问题依旧艰难
智通财经 · 07-19
港股异动 | 微创系全线走低 心脉医疗高价收购OMD引监管质疑 野村曾指长期债务问题依旧艰难
中泰证券给予心脉医疗买入评级,Q2业绩超预期,受让OMD股权增强主动脉介入综合竞争力
每日经济新闻 · 07-18
中泰证券给予心脉医疗买入评级,Q2业绩超预期,受让OMD股权增强主动脉介入综合竞争力
心脉医疗: 公司会在定期报告中披露报告期末的股东户数,请您关注并查阅有关定期报告
证星董秘互动 · 07-15
心脉医疗: 公司会在定期报告中披露报告期末的股东户数,请您关注并查阅有关定期报告
心脉医疗(688016.SH)获得滤器回收器医疗器械注册证
智通财经 · 07-15
心脉医疗(688016.SH)获得滤器回收器医疗器械注册证
母公司的“弃子” 心脉医疗溢价两倍收购并表
中国经营网 · 07-13
母公司的“弃子” 心脉医疗溢价两倍收购并表
心脉医疗最新公告:拟计划实施2024年度中期分红
证券之星 · 07-10
心脉医疗最新公告:拟计划实施2024年度中期分红
心脉医疗(688016.SH)拟计划实施2024年度中期分红
智通财经 · 07-10
心脉医疗(688016.SH)拟计划实施2024年度中期分红
心脉医疗大跌5.65% 北向资金连续2日增持
智选洞察 · 07-10
心脉医疗大跌5.65% 北向资金连续2日增持
机构最新调研路线图出炉 心脉医疗最受关注
第一财经 · 07-06
机构最新调研路线图出炉 心脉医疗最受关注
【机构调研记录】安信基金调研国盾量子、心脉医疗
证券之星 · 07-05
【机构调研记录】安信基金调研国盾量子、心脉医疗
【机构调研记录】博时基金调研九洲集团、心脉医疗等6只个股(附名单)
证券之星 · 07-05
【机构调研记录】博时基金调研九洲集团、心脉医疗等6只个股(附名单)
【机构调研记录】汇丰晋信基金调研万通发展、心脉医疗
证券之星 · 07-04
【机构调研记录】汇丰晋信基金调研万通发展、心脉医疗
【机构调研记录】易米基金调研华光环能、心脉医疗
证券之星 · 07-04
【机构调研记录】易米基金调研华光环能、心脉医疗
【机构调研记录】工银瑞信基金调研沈阳机床、心脉医疗
证券之星 · 07-04
【机构调研记录】工银瑞信基金调研沈阳机床、心脉医疗
【机构调研记录】东方基金调研万通发展、心脉医疗
证券之星 · 07-04
【机构调研记录】东方基金调研万通发展、心脉医疗
心脉医疗4.6亿元收购联营企业:系原上市公司破产清算资产重组设立
21世纪经济报道 · 07-03
心脉医疗4.6亿元收购联营企业:系原上市公司破产清算资产重组设立
国产心脏支架“卷”到国外,4.6亿元“吃”下欧洲合作商
健识局 · 07-03
国产心脏支架“卷”到国外,4.6亿元“吃”下欧洲合作商
中国银河:给予心脉医疗买入评级
证券之星 · 07-03
中国银河:给予心脉医疗买入评级
心脉医疗获中国银河买入评级,业绩保持高速增长,海外并购提升全球竞争实力
金融界 · 07-03
心脉医疗获中国银河买入评级,业绩保持高速增长,海外并购提升全球竞争实力
五粮液、心脉医疗等15股获融资净买入超5000万元
证券时报网 · 07-03
五粮液、心脉医疗等15股获融资净买入超5000万元
加载更多
公司概况
公司名称:
上海微创心脉医疗科技(集团)股份有限公司
所属行业:
专用设备制造业
上市日期:
2019-07-22
主营业务:
上海微创心脉医疗科技(集团)股份有限公司主要从事主动脉及外周血管介入医疗器械的研发、生产和销售。主要产品为胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司自成立以来,一直深耕于主动脉及外周血管介入医疗器械领域,通过多年的经验积累,公司已发展成我国主动脉血管介入医疗器械的龙头企业。公司产品已进入全国约1900家医院,主动脉产品国内市场占有率已连续多年排名国产品牌第一。
发行价格:
46.23
{"stockData":{"symbol":"688016","market":"SH","secType":"STK","nameCN":"心脉医疗","latestPrice":99.15,"timestamp":1721631600000,"preClose":96.9,"halted":0,"volume":2137279,"delay":0,"floatShares":123000000,"shares":123000000,"eps":4.4774,"marketStatus":"已收盘","marketStatusCode":5,"change":2.25,"latestTime":"07-22 15:00:00","open":96.94,"high":100.16,"low":96.55,"amount":211000000,"amplitude":0.0373,"askPrice":99.15,"askSize":25,"bidPrice":99.13,"bidSize":7,"shortable":0,"etf":0,"ttmEps":4.4774,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"adjPreClose":96.9,"symbolType":"stock_kcb","openAndCloseTimeList":[[1721611800000,1721619000000],[1721624400000,1721631600000]],"highLimit":106.59,"lowLimit":87.21,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":123262117,"pbRate":3.02,"roa":"--","roe":"4.51%","epsLYR":6.81,"committee":-0.126437,"marketValue":12221000000,"floatMarketCap":12221000000,"peRate":22.144549,"changeRate":0.0232,"turnoverRate":0.0173,"status":0,"afterMarket":{"amount":29745,"volume":300,"close":99.15,"buyVolume":0,"sellVolume":0,"time":1721633637153,"indexStatus":"已收盘 07-22 15:30:00","preClose":96.9}},"requestUrl":"/m/hq/s/688016","defaultTab":"news","newsList":[{"id":"2452412392","title":"港股异动 | 微创系全线走低 心脉医疗高价收购OMD引监管质疑 野村曾指长期债务问题依旧艰难","url":"https://stock-news.laohu8.com/highlight/detail?id=2452412392","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452412392?lang=zh_cn&edition=full","pubTime":"2024-07-19 14:36","pubTimestamp":1721370989,"startTime":"0","endTime":"0","summary":"消息面上,7月2日,心脉医疗发布公告称,公司全资子公司荷兰心脉拟使用自有资金6500万美元收购OMD公司72.37%股权。对此,监管就交易估值对价合理性及交易方是否存在潜在利益等一系列问题发出质疑。据微创医疗2023年年报,企业现金流已现吃紧迹象。野村此前研报指出,公司短期内情况或有好转,长期债务问题依旧艰难。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153073.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","YANG","HSCEI","00853","BK0251","688016","BK1585","BK1589","02252","02172","BK1100","HSTECH"],"gpt_icon":1},{"id":"2452110454","title":"中泰证券给予心脉医疗买入评级,Q2业绩超预期,受让OMD股权增强主动脉介入综合竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2452110454","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452110454?lang=zh_cn&edition=full","pubTime":"2024-07-18 08:55","pubTimestamp":1721264100,"startTime":"0","endTime":"0","summary":"中泰证券07月18日发布研报称,给予心脉医疗(688016.SH,最新价:95.35元)买入评级。评级理由主要包括:1)血管介入核心产品不断发力,单季度业绩持续高增;2)并购血管介入特色龙头OMD,有望助力海外市场加速开拓。风险提示:新产品研发风险、市场竞争加剧风险、研究报告使用的公开资料可能存在信息滞后或更新不及时的风险等。AI点评:心脉医疗近一个月获得2份券商研报关注,买入1家。(文章来源:每日经济新闻)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180900239f60bad9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180900239f60bad9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600918","688016"],"gpt_icon":0},{"id":"2451649245","title":"心脉医疗: 公司会在定期报告中披露报告期末的股东户数,请您关注并查阅有关定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2451649245","media":"证星董秘互动","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451649245?lang=zh_cn&edition=full","pubTime":"2024-07-15 20:01","pubTimestamp":1721044887,"startTime":"0","endTime":"0","summary":"证券之星消息,心脉医疗(688016)07月15日在投资者关系平台上答复投资者关心的问题。投资者:您好,请问公司是否可以告知截止今日的股东数量,谢谢心脉医疗董秘:尊敬的投资者,您好!公司会在定期报告中披露报告期末的股东户数,请您关注并查阅有关定期报告。感谢您对公司的关注!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071520050595c04a50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071520050595c04a50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2451619836","title":"心脉医疗(688016.SH)获得滤器回收器医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2451619836","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451619836?lang=zh_cn&edition=full","pubTime":"2024-07-15 17:12","pubTimestamp":1721034754,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心脉医疗(688016.SH)发布公告,公司控股子公司上海蓝脉医疗科技有限公司获得国家药品监督管理局颁发的关于滤器回收器的医疗器械注册证,该产品预期通过抓捕器经皮移除下腔静脉滤器。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150956.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688016","09997","09996","BK1100","BK1583","BK0251","159883","BK1574","BK1222"],"gpt_icon":0},{"id":"2451422568","title":"母公司的“弃子” 心脉医疗溢价两倍收购并表","url":"https://stock-news.laohu8.com/highlight/detail?id=2451422568","media":"中国经营网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451422568?lang=zh_cn&edition=full","pubTime":"2024-07-13 03:51","pubTimestamp":1720813860,"startTime":"0","endTime":"0","summary":"心脉医疗将此归结为OMD业务经营持续向好,经营业绩迎来快速发展期等原因。心脉医疗在公告中表示,OMD近两年亏损逐步收窄,今年一季度已处于微亏状态,根据其目前的经营情况,预计在今年实现扭亏为盈。但据心脉医疗披露,ETC在2018年及2019年的营收稳定提升,亏损收窄,并表示其逐步能够可持续经营。OMD销售心脉医疗产品产生的收入逐年增加。心脉医疗方面表示,未来OMD的业绩持续增长及盈利具备长期持续性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071303530995af5f9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071303530995af5f9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2450813071","title":"心脉医疗最新公告:拟计划实施2024年度中期分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2450813071","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450813071?lang=zh_cn&edition=full","pubTime":"2024-07-10 22:00","pubTimestamp":1720620037,"startTime":"0","endTime":"0","summary":"心脉医疗公告,拟计划实施2024年度中期分红,在2024年半年度具有可供分配利润的条件下,实施2024年度中期分红比例不低于2024年半年度归属于上市公司股东净利润的50%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000047080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2450878818","title":"心脉医疗(688016.SH)拟计划实施2024年度中期分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2450878818","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450878818?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:36","pubTimestamp":1720618595,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心脉医疗(688016.SH)发布公告,根据相关规定,同时结合公司的实际情况及未来发展的需要,公司拟计划实施2024年度中期分红。在2024年半年度具有可供分配利润的条件下,实施2024年度中期分红比例不低于2024年半年度归属于上市公司股东净利润的50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1149043.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2450881943","title":"心脉医疗大跌5.65% 北向资金连续2日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2450881943","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450881943?lang=zh_cn&edition=full","pubTime":"2024-07-10 09:49","pubTimestamp":1720576171,"startTime":"0","endTime":"0","summary":"资金动向截止发稿,心脉医疗获得主力净流出563万元,其中超大单流出538万元,大单流出24万元。北向资金方面,心脉医疗07月09日获得北向资金增持0.57万股,截至07月09日,北向资金当前共持有心脉医疗90.22万股,市值8731万元,持股占流通股比为0.73%。最新财报显示,今年一季报,心脉医疗实现营业收入3.58亿元,同比增长25.38%,净利润为1.84亿元,同比增长47.62%,基本每股收益为2.23元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710094938af917826&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710094938af917826&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2449942292","title":"机构最新调研路线图出炉 心脉医疗最受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2449942292","media":"第一财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449942292?lang=zh_cn&edition=full","pubTime":"2024-07-06 00:00","pubTimestamp":1720195238,"startTime":"0","endTime":"0","summary":"Wind数据显示,机构本周共调研了210家上市公司,其中心脉医疗最获关注,参与调研的机构达250家。伟创电气、耐普矿机、华锐精密均获超100家机构调研。据统计,艾力斯获机构调研7次,冀东水泥、友发集团等8股均获调研3次。从调研行业来看,机构持续聚焦工业机械、电子元件、半导体产品等板块。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706000048aef8308b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706000048aef8308b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2449556406","title":"【机构调研记录】安信基金调研国盾量子、心脉医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2449556406","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449556406?lang=zh_cn&edition=full","pubTime":"2024-07-05 08:01","pubTimestamp":1720137697,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月4日披露的机构调研信息,安信基金近期对2家上市公司进行了调研,相关名单如下:1)国盾量子 个股亮点:公司主要产品包括量子保密通信网络核心设备、量子安全应用产品、核心组件以及管理与控制软件四大门类。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500010211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0214","688016","688027","BK0251"],"gpt_icon":0},{"id":"2449406378","title":"【机构调研记录】博时基金调研九洲集团、心脉医疗等6只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2449406378","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449406378?lang=zh_cn&edition=full","pubTime":"2024-07-05 08:01","pubTimestamp":1720137689,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月4日披露的机构调研信息,博时基金近期对6家上市公司进行了调研,相关名单如下:1)九洲集团 个股亮点:九洲转2于2021-01-08上市;公司有交直流电动汽车充电桩产品。3)思特威 个股亮点:公司是全球安防CMOS图像传感器龙头,出货量位居全球第一。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500010197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0078","BK0028","300040","BK0224","BK0186","688016","BK0251","BK0156","BK0136"],"gpt_icon":0},{"id":"2448454718","title":"【机构调研记录】汇丰晋信基金调研万通发展、心脉医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2448454718","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448454718?lang=zh_cn&edition=full","pubTime":"2024-07-04 08:02","pubTimestamp":1720051323,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月3日披露的机构调研信息,汇丰晋信基金近期对2家上市公司进行了调研,相关名单如下:1)万通发展 个股亮点:公司将稀布相控阵技术与5G毫米波相控阵芯片及低轨卫星终端相控阵芯片的专业化设计能力结合起来,支撑5G毫米波相控阵T/R芯片国产化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400010874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0172","600246","BK0088","BK0273","688016"],"gpt_icon":0},{"id":"2448540794","title":"【机构调研记录】易米基金调研华光环能、心脉医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2448540794","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448540794?lang=zh_cn&edition=full","pubTime":"2024-07-04 08:01","pubTimestamp":1720051318,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月3日披露的机构调研信息,易米基金近期对2家上市公司进行了调研,相关名单如下:1)华光环能 个股亮点:公司可在环保设施建设等方面参与新型城镇化建设。旗下最近一年表现最佳的公募基金产品为易米和丰债券A,最新单位净值为1.4,近一年增长0.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400010865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0218","688016","BK0147","BK0251","BK0150","600475","BK0134"],"gpt_icon":0},{"id":"2448454741","title":"【机构调研记录】工银瑞信基金调研沈阳机床、心脉医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2448454741","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448454741?lang=zh_cn&edition=full","pubTime":"2024-07-04 08:01","pubTimestamp":1720051310,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月3日披露的机构调研信息,工银瑞信基金近期对2家上市公司进行了调研,相关名单如下:1)沈阳机床 个股亮点:公司智能机床制造;公司机床行业龙头企业;公司主营业务包括数控机床2)心脉医疗 心脉医疗2024年一季报显示,公司主营收入3.58亿元,同比上升25.38%;归母净利润1.84亿元,同比上升47.62%;扣非净利润1.78亿元,同比上升48.91%;负债率9.69%,投资收益712.77万元,财务费用-435.64万元,毛利率76.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400010855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0061","BK0251","688016","BK0071","000410","BK0130","BK0005","BK0201","BK0259"],"gpt_icon":0},{"id":"2448211454","title":"【机构调研记录】东方基金调研万通发展、心脉医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2448211454","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448211454?lang=zh_cn&edition=full","pubTime":"2024-07-04 08:01","pubTimestamp":1720051272,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月3日披露的机构调研信息,东方基金近期对2家上市公司进行了调研,相关名单如下:1)万通发展 个股亮点:公司将稀布相控阵技术与5G毫米波相控阵芯片及低轨卫星终端相控阵芯片的专业化设计能力结合起来,支撑5G毫米波相控阵T/R芯片国产化。旗下最近一年表现最佳的公募基金产品为东方周期优选灵活配置混合A,最新单位净值为0.78,近一年增长19.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407040802449eff48c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407040802449eff48c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600246","BK0273","BK0172","688016","BK0251","BK0088"],"gpt_icon":0},{"id":"2448107618","title":"心脉医疗4.6亿元收购联营企业:系原上市公司破产清算资产重组设立","url":"https://stock-news.laohu8.com/highlight/detail?id=2448107618","media":"21世纪经济报道","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448107618?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:42","pubTimestamp":1720010557,"startTime":"0","endTime":"0","summary":"心脉医疗表示,根据OMD目前的经营情况,预计于2024年度实现扭亏为盈,其经营业绩于2024年迎来盈利拐点。另外还值得关注的是,OMD系由原纳斯达克上市公司Lombard Medical, Inc.破产清算的核心资产重组设立。EVAR 因未能满足股票交易价格相关要求,2017年11月9日起退市,2018年EVAR因持续经营亏损及无力偿还到期债务,进行破产清算及重组。腹主动脉腔内介入手术中,其产品占比23%,居国产首位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703204811956de7fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703204811956de7fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2448613107","title":"国产心脏支架“卷”到国外,4.6亿元“吃”下欧洲合作商","url":"https://stock-news.laohu8.com/highlight/detail?id=2448613107","media":"健识局","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448613107?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:19","pubTimestamp":1720009189,"startTime":"0","endTime":"0","summary":"7月2日, 心脉医疗 发布公告:公司全资子公司荷兰心脉拟使用自有资金6500万美元受让Earl Intellect Limited、Turbo Heart Limited合计持有的OMD公司72.37%股权,折合人民币超4.6亿元,以此全资收购OMD公司。然而,根据心脉医疗的公告,OMD公司连年亏损,心脉医疗只是预估2024年OMD公司将有正面业绩。2022年,心脉医疗重新增资2100万美元,认购OMD公司近28%的A轮优先股股权,使其成为心脉医疗联营公司。根据公告,OMD公司核心品种自退市以来并无增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407032030309efbd5e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407032030309efbd5e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2448147328","title":"中国银河:给予心脉医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2448147328","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448147328?lang=zh_cn&edition=full","pubTime":"2024-07-03 12:03","pubTimestamp":1719979411,"startTime":"0","endTime":"0","summary":"中国银河证券股份有限公司程培,孟熙近期对心脉医疗进行研究并发布了研究报告《业绩保持高速增长,海外并购提升全球竞争实力》,本报告对心脉医疗给出买入评级,当前股价为103.09元。同时,心脉医疗拟通过此次收购建立欧洲市场业务平台,搭建多个境外业务中心实现市场的深度覆盖,进而深化推进国际化战略。最新盈利预测明细如下:该股最近90天内共有15家机构给出评级,买入评级12家,增持评级3家;过去90天内机构目标均价为194.32。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070300024925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","601881"],"gpt_icon":0},{"id":"2448472191","title":"心脉医疗获中国银河买入评级,业绩保持高速增长,海外并购提升全球竞争实力","url":"https://stock-news.laohu8.com/highlight/detail?id=2448472191","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448472191?lang=zh_cn&edition=full","pubTime":"2024-07-03 12:02","pubTimestamp":1719979362,"startTime":"0","endTime":"0","summary":"7月3日,心脉医疗获中国银河买入评级,近一个月心脉医疗获得2份研报关注。研报预计2024年-2026年心脉医疗的归母净利分别为6.67亿元、9.00亿元和12.11亿元。研报认为,心脉医疗是国内主动脉 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20240703/c659440727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["688016","601881"],"gpt_icon":0},{"id":"2448152148","title":"五粮液、心脉医疗等15股获融资净买入超5000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448152148","media":"证券时报网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448152148?lang=zh_cn&edition=full","pubTime":"2024-07-03 09:39","pubTimestamp":1719970793,"startTime":"0","endTime":"0","summary":"证券时报网讯,Wind统计显示,7月2日有1691只个股获融资净买入,净买入金额在2000万元以上的有68只。其中,15只获融资净买入额超5000万元。五粮液获融资净买入额居首,净买入1.49亿元;融资净买入金额居前的还有心脉医疗、潍柴动力、格力电器、长江电力、新易盛。净买入额分别为1.06亿元、0.96亿元、0.92亿元、0.9亿元、0.84亿元。校对:杨立林","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703093955956a7353&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703093955956a7353&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1064130708.USD","LU0043850808.USD","LU1328615791.USD","000858","LU0819121731.USD","LU1781817850.SGD","LU2097828805.USD","688016","BK0164","LU0862451753.SGD","LU1655091616.SGD","LU2148510915.USD","LU0370786039.SGD","LU0856984785.SGD","LU1969619763.USD","LU0572944931.SGD","BK0215","LU2097828557.USD","BK0183","BK0251","LU2097828631.EUR","LU2097828714.EUR","BK0187","LU0048580855.USD","LU2097828474.EUR","BK0175","LU0890818403.SGD","BK0188","LU1580142542.USD","LU2328871848.SGD","BK0028","LU1064131003.USD","LU0327786744.USD","BK0012","BK0196"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-07-22","address":"上海市浦东新区康新公路3399弄1号","stockEarnings":[{"period":"1week","weight":0.0706},{"period":"1month","weight":-0.0575},{"period":"3month","weight":-0.1443},{"period":"6month","weight":-0.1312},{"period":"1year","weight":-0.1427},{"period":"ytd","weight":-0.2284}],"companyName":"上海微创心脉医疗科技(集团)股份有限公司","boardCode":"AI0035","perCapita":"11803股","boardName":"专用设备制造业","registeredCapital":"12326万元","compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0191},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":-0.0036}],"survey":" 上海微创心脉医疗科技(集团)股份有限公司主要从事主动脉及外周血管介入医疗器械的研发、生产和销售。主要产品为胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司自成立以来,一直深耕于主动脉及外周血管介入医疗器械领域,通过多年的经验积累,公司已发展成我国主动脉血管介入医疗器械的龙头企业。公司产品已进入全国约1900家医院,主动脉产品国内市场占有率已连续多年排名国产品牌第一。","serverTime":1721668008813,"listedPrice":46.23,"stockholders":"10443人(较上一季度增加3.19%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心脉医疗,688016,心脉医疗股票,心脉医疗股票老虎,心脉医疗股票老虎国际,心脉医疗行情,心脉医疗股票行情,心脉医疗股价,心脉医疗股市,心脉医疗股票价格,心脉医疗股票交易,心脉医疗股票购买,心脉医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}